- Home
- HITI vs SCPH Comparison
HITI vs SCPH Comparison
Compare HITI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- SCPH
- Stock Information
- Founded
- HITI 2009
- SCPH 2013
- Country
- HITI Canada
- SCPH United States
- Employees
- HITI N/A
- SCPH N/A
- Industry
- HITI
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- HITI
- SCPH Health Care
- Exchange
- HITI Nasdaq
- SCPH Nasdaq
- Market Cap
- HITI 178.6M
- SCPH 299.0M
- IPO Year
- HITI N/A
- SCPH 2017
- Fundamental
- Price
- HITI $3.63
- SCPH $5.62
- Analyst Decision
- HITI Strong Buy
- SCPH Buy
- Analyst Count
- HITI 2
- SCPH 3
- Target Price
- HITI $4.75
- SCPH $12.00
- AVG Volume (30 Days)
- HITI 1.0M
- SCPH 2.3M
- Earning Date
- HITI 09-15-2025
- SCPH 11-12-2025
- Dividend Yield
- HITI N/A
- SCPH N/A
- EPS Growth
- HITI N/A
- SCPH N/A
- EPS
- HITI N/A
- SCPH N/A
- Revenue
- HITI $398,202,371.00
- SCPH $49,969,000.00
- Revenue This Year
- HITI $12.17
- SCPH $108.95
- Revenue Next Year
- HITI $21.96
- SCPH $78.30
- P/E Ratio
- HITI N/A
- SCPH N/A
- Revenue Growth
- HITI 9.22
- SCPH 107.79
- 52 Week Low
- HITI $1.64
- SCPH $1.94
- 52 Week High
- HITI $3.66
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- HITI 67.68
- SCPH 63.83
- Support Level
- HITI $3.24
- SCPH $4.33
- Resistance Level
- HITI $3.48
- SCPH $5.62
- Average True Range (ATR)
- HITI 0.17
- SCPH 0.04
- MACD
- HITI -0.02
- SCPH 0.01
- Stochastic Oscillator
- HITI 93.75
- SCPH 85.71
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.